Nile Red Quantifier:A novel and quantitative tool to study lipid accumulation in patient-derived circulating monocytes using confocal microscopy by Schnitzler, Johan G et al.
  
 University of Groningen
Nile Red Quantifier
Schnitzler, Johan G; Bernelot Moens, Sophie J; Tiessens, Feiko; Bakker, Guido J; Dallinga-
Thie, Geesje M; Groen, Albert K; Nieuwdorp, Max; Stroes, Erik S G; Kroon, Jeffrey
Published in:
Journal of Lipid Research
DOI:
10.1194/jlr.D073197
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Schnitzler, J. G., Bernelot Moens, S. J., Tiessens, F., Bakker, G. J., Dallinga-Thie, G. M., Groen, A. K., ...
Kroon, J. (2017). Nile Red Quantifier: A novel and quantitative tool to study lipid accumulation in patient-
derived circulating monocytes using confocal microscopy. Journal of Lipid Research, 58(11), 2210-2219.
https://doi.org/10.1194/jlr.D073197
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
2210 Journal of Lipid Research Volume 58, 2017
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.
This article is available online at http://www.jlr.org
Supplementary key words  lipid droplets • methods • cholesterol and 
trafficking • fluorescence and confocal imaging
Atherosclerosis is characterized by the recruitment of 
inflammatory cells  into  the  intima, where excessive uptake  
of modified LDL particles, such as oxidized LDL, by mono-
cytes and macrophages leads to foam cell formation (1), 
promoting the initiation of atherosclerotic lesions. Subse-
quent  endothelial  activation  leads  to  continuous  recruit-
ment of circulating monocytes into the subintimal area, 
further  increasing  inflammatory  activity  of  these  lesions, 
leading  to  plaque  progression  and,  eventually,  plaque 
destabilization (2–4). Recently, it has been suggested that 
migration of circulating monocytes is not merely a reflec-
tion of local endothelial activation near atherogenic areas, 
but  circulating  monocytes  may  also  display  pro-adhesive 
properties in patients at increased cardiovascular risk (5). 
The factors leading to this systemic activation of circulating 
monocytes remain to be established. In dyslipidemic states, 





Abstract The inflammatory profile of circulating mono-
cytes is an important biomarker for atherosclerotic plaque 
vulnerability. Recent research revealed that peripheral lipid 
uptake by monocytes alters their phenotype toward an in-
flammatory state and this coincides with an increased lipid 
droplet (LD) content. Determination of lipid content of cir-
culating monocytes is, however, not very well established. 
Based on Nile Red (NR) neutral LD imaging, using confocal 
microscopy and computational analysis, we developed NR 
Quantifier (NRQ), a novel quantification method to assess 
LD content in monocytes. Circulating monocytes were iso-
lated from blood and used for the NR staining procedure. In 
monocytes stained with NR, we clearly distinguished, based 
on 3D imaging, phospholipids and exclusively intracellular 
neutral lipids. Next, we developed and validated NRQ, a 
semi-automated quantification program that detects altera-
tions in lipid accumulation. NRQ was able to detect LD al-
terations after ex vivo exposure of isolated monocytes to 
freshly isolated LDL in a time- and dose-dependent fashion. 
Finally, we validated NRQ in patients with familial hypercho-
lesterolemia and obese subjects in pre- and postprandial 
state.  In conclusion, NRQ is a suitable tool to detect even 
small differences in neutral LD content in circulating mono-
cytes using NR staining.—Schnitzler, J. G., S. J. Bernelot 
Moens, F. Tiessens, G. J. Bakker, G. M. Dallinga-Thie, A. K. 
Groen, M. Nieuwdorp, E.  S. G.  Stroes,  and  J. Kroon. Nile 
Red Quantifier: a novel and quantitative tool to study lipid 
accumulation in patient-derived circulating monocytes using 
confocal microscopy J. Lipid Res. 2017. 58: 2210–2219.
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(6), as well as  increased monocyte-derived production of 
tumor necrosis factor  and interleukin 1 (7). In this con-




In cells, lipids are usually stored in lipid droplets (LDs) 
(11, 12). LDs have been  identified as organelles  that are 
actively involved in many essential cellular functions, such 
as cellular homeostasis (membrane biogenesis and lipo-
protein synthesis), cell  survival  in a nutrient-poor milieu, 
protein storage, and protection against lipotoxicity by scav-















more importantly, quantification of lipid particles is arbi-




Here,  we  set  out  to  develop  a  fast  and  quantitative 
method to quantify neutral LDs in circulating mono-
cytes stained with the lysochrome, Nile Red (NR), first 
described in peritoneal macrophages by Greenspan, Mayer, 
and Fowler  (21)  in  1985. Greenspan  and others  consid-
ered NR as an environment-sensitive fluorescent dye used 
to detect  intracellular  lipid particles with high sensitivity 
(21, 22) in multiple cell types (11) by high-resolution confo-
cal laser scanning microscopy. For quantification of the cyto-
plasmic neutral LDs, we developed Nile Red Quantifier 
(NRQ),  a MATLAB-based  freely  available program  for 













Next, cells were centrifuged for 20 min at 600 g at room tempera-
ture with slow acceleration and no brake. The peripheral blood 





er’s protocol (Miltenyi, Bergisch Gladbach, Germany). In short, 
cells were  resuspended  in MACS buffer  [0.5% bovine  serum 
albumin (Sigma-Aldrich, St. Louis, MO) in PBS/2 mM EDTA]. 
Next,  CD14 MicroBeads  (Miltenyi  Biotec,  Leiden, The Nether-
lands) were added and incubated for 30 min at 4°C. After incuba-
tion, the cells were washed with MACS buffer and resuspended in 
MACS buffer for CD14 bead isolation using MACS separation col-
umns  (Miltenyi  Biotec).  After  isolation,  cells  were  counted  by 
means of a CASY counter. Monocytes were kept in Iscove’s modi-




were  exclusively  performed  with  freshly  isolated  circulating 
monocytes.
LD and neutral lipid extraction
LD extraction  from peripheral monocytes was performed on 
10 × 106 CD14+ monocytes according to the manufacturer’s in-
structions (#MET-5011; Cell Biolabs Inc., San Diego, CA). Next, 
density gradient ultracentrifugation in a SW41 rotor (Beckman, 
Uithoorn, The Netherlands) was performed for 3 h at 20,000 g at 
4°C. The top layer, containing the floating LDs, was collected and 
used  for neutral  lipid extraction. Lipids were  isolated,  as previ-








The neutral  lipid  extractions were  analyzed using  a LC-4000 
series UHPLC system (Jasco, Tokyo, Japan). A 5 ul volume of sam-
ple was injected with a Jasco AS-4250 UHPLC autosampler (Jasco) 









LDL isolation by ultracentrifugation









polystyrene  SW41  tube  (Beckman).  The  gradient  was  built  by 
carefully consecutively pipetting 2.0 ml KBr solution with d = 1.225, 
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100 ultracentrifuge system (Beckman, Fullerton, CA). After cen-
trifugation,  LDL  fractions  were  harvested  by  tube  slicing  and 
cholesterol, TGs, and apoB concentrations were measured using 
commercially  available  enzymatic  assays  (Diasys,  Holzheim, 
Germany) on a Selectra system (Sopachem, Ochten, The Nether-
lands). Prior to the experiments, the fractions were dialyzed for 
24 h in PBS, which was changed at least three times. Next, the 
isolated  and dialyzed LDL  samples were filter  sterilized using 
0.45 m Minisart® syringe filters (Sartorius, Göttinger, Germany). 
Incubation experiments with LDL were normalized to apoB con-
centrations. For the dose-response and time incubation studies, 










NR lipid content staining of CD14+ monocytes
The NR (9-diethylamino-5H-benzo[]phenoxazine-5-one) stain-
ing solution (1 mM) was prepared by dissolving 318 g/ml NR in 
DMSO and filtering through a 0.22 m Minisart® syringe filter 
(Sartorius) in order to reduce fluorescent background. Aliquots 
were stored at 20°C for at least 6 months. The working solution 
was prepared  freshly by dissolving NR stock  solution  in an  isos-
motic and isotonic solution (BD FACS buffer) to a final concen-











erlands)  for  15  min.  Cells  were  washed  in  PBS  (pH  7.4)  and 
mounted using fluorescent mounting medium (Dako).
Image acquisition
Imaging  was  performed  on  a  Leica  TCS  SP8  confocal  laser 
scanning  DMI6000  inverted  microscope  (Leica  Microsystems, 
Wetzlar, Germany) using a 63×/1.40 oil CS2 objective coupled to 
a  Hamamatsu  camera.  Phospholipids  were  excited  at  590  nm 




(FOV),  as well  as  the number of LDs per positive monocyte  in 
5–10 FOVs. In order to visualize all LDs in the cell, resolution was 
significantly enhanced through a digital magnification of 1.5–2, 
z-stack images of 0.75 m per stack (1,024 × 1,024 pixels × 8 bit), 
and  subsequently merged  into  a maximum  intensity  projec-






Quantification of LDs using MATLAB™ AMC NRQ
The  cell  and  lipid  counter,  named  NRQ,  is  a  custom-made 
stand-alone program with  in-house-created code  in MATLABTM 
2015b (The MathWorks Inc., Natick, MA). NRQ is based on semi-
automated  segmentation,  where  the  user  has  to  point  out  and 
click on  the cells  in  the  image,  leaving a mark  for  recognition. 







a user-defined size and, subsequently, the image is contrast 
enhanced. The 2D cell segmentation is performed and enables 
monocyte detection, as well as removal of monocytes touching the 
edges, because lipid count is incomplete in these cells. This binary 
mask, dilated with a user-defined size, is visualized on the original 
image to check to determine whether LDs are within these masks. 
LDs are segmented by creating a binary lipid mask, as described 
earlier. The hue, saturation, and value (HSV) segmentation method 
is used to identify boundaries of objects, making it suitable for 
segmentation. This enables the detection of LDs, for which value 
(color range) is modifiable to user preference or dye. Next, the 
background  correction  is  applied  by  subtracting  the  inverse 
monocyte cell mask  from  the LD mask  to avoid possible  lipids 
located outside cell regions. Although LDs in isolated monocytes 
are spherically shaped, in general, the space between LDs can be 
small and segmentation can lead to overlapping lipids. To distin-
guish  individual  LDs  from  connected  LDs  in  the  mask,  shape 
measurements are computed. Subsequently, the original image 
with the transparent monocyte cell-mask  is displayed. A new bi-
nary monocyte  cell mask, with  a  user-defined octagonal  size,  is 
created using these marks. Detailed descriptions regarding the 
MATLAB code can be found in the supplemental data.
Validation of NR lipid content assessment using ORO
The ORO staining solution was made by dissolving 50 mg of 




















and  inflammatory  response  upon  LDL  exposure.  THP-1  cells 
were cultured in RPMI 1640 GlutaMAX-medium (Thermo Fisher 
Scientific) supplemented with 10% FBS (Bodinco, Alkmaar, The 
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Netherlands), penicillin  (100 U/ml; Thermo Fisher Scientific), 
and streptomycin (100 mg/ml; Thermo Fisher Scientific) at 37°C 




centrifuge (Thermo Fisher Scientific) for 2 min at 34 g. After fixa-
tion,  cells  were  incubated  with  NR  for  subsequent  neutral  LD 
analysis.
Clinical validation
Previous  studies  reported  the  presence  of  lipid-laden mono-




zygous FH patients  (30) currently not  receiving  therapy due  to 
statin-associated muscle symptoms (31) and compared them to 
age and gender matched healthy controls and b) three obese sub-











and  as  number  (percentage)  for  categorical  variables,  unless 
stated otherwise. Correlations were assessed using univariate lin-
ear regression. Time- and dose-dependency experiments were as-
sessed  with  a  one-way  ANOVA Dunnett’s method  for multiple 
comparisons. The agreement between experiments and analyses 








NR imaging in peripheral human CD14+ monocytes
The accumulation of lipids in circulating monocytes 
were detected with the NR lipid dye, which visualized both 
phospholipids and neutral lipids by high resolution confocal 




of  membrane-bound  cholesterol  was  reduced  until  LDs 
alone were visible (supplemental Fig. S1A). The advantage 
of the phospholipid staining is that it results in a clear 
plasma membrane staining that can be used to assess 
whether neutral lipids are stored within cell bodies, whereas 
other lipid dyes often require alternative fluorescent labels 
for  this  purpose  (33).  To  test  whether  NR  staining  was 
equivalent to ORO, we examined lipid accumulation in iso-
lated monocytes (exposed to 50 g/ml LDL for 1 h) and 
stained LDs using both ORO and NR. Imaging of ORO-




the  same monocyte  pool  is  shown  in  Fig.  1C. As  can  be 
seen,  both NR  and ORO were  able  to  stain  intracellular 
LDs. However,  the use of methanol  in  the ORO staining 
procedure promotes fusion of LDs (34, 35).
It is crucial to determine whether LDs are located within 
the isolated monocytes because the presence of artifacts 
(i.e., background signal outside of the cell perimeter) may 
result  in false positive LD quantification. For this reason, 
we  either  incubated  isolated  monocytes  with  or  without 
freshly isolated LDL (50 g/ml) and made an extensive 
z-stack that was subsequently modeled into a 3D structure 
in order to establish the LD localization in great detail (Fig. 
1D; supplemental Movies S1, S2). Addition of LDL resulted 
in elevated intracellular neutral lipids when compared with 
nontreated monocytes, indicating that the lipid content of 
LDL particles is routed toward LDs. This concomitantly in-




isolated  circulating monocytes  that  were  incubated  with 
human LDL (0, 1, or 2 mg/ml apoB). Next, neutral lipids 
were  separated  from  phospholipids  and  analyzed  on 
HPLC. This  revealed  a dose-dependent  increase  in CE/
TG ratio (CE/TG 3.46, 8.28 vs. 1.00-fold for 1, 2 vs. 0 mg/ml 
LDL, respectively;  supplemental Fig. S1B). This  implies 
that increased lipid loading of monocytes corresponds 




(n = 3) FH (n = 3) P Pre-meal Post-meal
P (Pre-meal  
vs. Post-meal)
Age, years 60 ± 10 61 ± 12 0.908 56 ± 12 n/a n/a
Gender, n, male (%) 3 (100) 3 (100) n/a 3 (100) n/a n/a
BMI n/a n/a n/a 38.3 ± 5.27 n/a n/a
Total cholesterol, mmol/l 5.2 ± 0.9 8.8 ± 0.6 0.005 4.75 ± 0.11 4.97 ± 0.07 0.056
LDL-C, mmol/l 3.4 ± 0.6 6.9 ± 0.7 0.002 n/a n/a n/a
HDL-C, mmol/l 1.4 ± 0.3 1.0 ± 0.2 0.130 n/a n/a n/a
TGs, mmol/l 1.45 ± 0.3 1.78 ± 0.1 0.126 2.13 ± 0.29 3.27 ± 0.85 0.103
Values are n (%) or mean ± SD. HDL-C, HDL cholesterol; LDL-C, LDL cholesterol; n/a, not applicable.
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Validation of NRQ
Automated quantification of NR-stained monocytes pro-
vides a tool for detecting neutral LDs in a standardized and 
nonarbitrary manner. Here, we created and used a semi-
automated segmentation to quantify LDs in the cells using 
the NRQ. The multiple NRQ processing steps are shown in 




lipid count in these areas (Fig. 2D). After counting all LDs 
found in the FOV (Fig. 2E), based on the green channel 
(neutral lipids) in the RGB image, all LDs located outside 
the perimeter of the phospholipid monocyte membrane 
were excluded from the calculations, a process also known 
as background correction (Fig. 2F). Although LDs in iso-
lated monocytes are spherically shaped in general, the 
space between LDs can be  small  and  segmentation can 
lead to overlapping lipids. To distinguish individual LDs 
from connected LDs in the mask, shape measurements 
were computed. Next,  thresholds were set for these mea-
surements to complete LD count (supplemental Fig. S3A–E). 




by creating marks close to the center of each monocyte. 
Subsequently, the original image is displayed together with 
the  transparent monocyte  cell-mask.  Next,  lipid-positive 
monocytes were counted by subtracting the inverted bi-







lowing sections will be discussed: a) precision, b) reproduc-
ibility, and c) accuracy.
Repeatability and reproducibility
To assess repeatability of the method, as shown in sup-
plemental Fig. S2, the obtained blood from one single do-
nor (circled 1 in figure) was split into two equal portions 
(circled 2) for monocyte isolation (circled 3). These mono-
cytes were divided over three microscope slides (circled 4) 





In order  to  address  reproducibility, we  isolated mono-
cytes from one individual and divided these over six micro-
scope slides. These six microscope slides were subsequently 
imaged  on  two  occasions  by  two  independent  observers 
and counted manually. Agreement of the inter-observer 
was excellent for lipid-positive monocytes and LDs per pos-










the  LD  counts  per  monocyte  were  plotted  against  each 
other in order to perform a linear regression analysis. As 
depicted in Fig. 2H, I, an r2 of 0.8273 was found for cir-
culating monocytes, whereas THP-1 cells showed an r2 of 
0.7430. Although, the r2 of both graphs indicated that the 




tive  images  of ORO-stained monocytes  incubated with  50 g/ml 
LDL for 1 h. The left image shows LDs by bright-field microscopy; 
LDs are indicated with white arrows. The right image was obtained 
by  confocal  microscopy.  LDs  are  shown  in  green.  C:  NR-stained 
monocytes treated with 50 g/ml LDL for 1 h. LDs are shown in 
green. Scale bar, 10 m. D: The 3D images of monocytes (gray bod-
ies  shown on  left  images)  untreated  (upper  images)  and  treated 
(lower images) for 1 h with 50 g/ml LDL. LDs are shown in green.
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NRQ was accurate when compared with manual counting 
of LDs, the amounts of LDs counted by the NRQ tended to 
be  higher  compared  with  the  manually  determined  LD 
count. This  phenomenon most  likely  reflected  the  accu-
racy of detecting LDs by  the NRQ. As mentioned  in  the 






Ex vivo lipid uptake by human peripheral CD14+ 
monocytes
To assess whether NR, as quantified by NRQ, was able to 
detect differences in lipid uptake in monocytes, a time 
course  experiment  was  conducted.  Isolated  monocytes 
were incubated with 50 g/ml LDL for different times, as 
indicated, and lipid accumulation (Fig. 3A)  was  subse-
quently analyzed by assessing the increase in intracellular 
LDs and the percentage of lipid-positive cells (Fig. 3B, C, 
respectively). After 5 min of incubation with LDL, a signifi-
cant  increase  in  LDs  per  positive  monocyte  was  already 
found (1.231 ± 0.139-fold; Fig. 3C). As shown in Fig. 3B, the 
number  of  lipid-positive monocytes  after  30 min  (85.6  ± 
6.12%) and 60 min (86.8 ± 5.00%) significantly increased 
compared  with  baseline  (63.8  ±  2.72%).  This  coincided 
with an increase in LDs per LD-positive monocyte (Fig. 3C) 
after 30 min (1.705 ± 0.151-fold) and 60 min (1.660 ± 0.112-
fold). Altogether, the LDL uptake indicates, in a time- 







gest that LDL is taken up by monocytes leading to intracel-
lular lipid body formation detectable by NR. To determine 
whether LDL uptake  is mediated  by  receptors,  the  cells 
were incubated with 50 g/ml LDL and either fixed with 
4% paraformaldehyde or incubated at 4°C to induce meta-
bolic arrest (supplemental Fig. S4A, B and supplemental 
Fig. S4C, D,  respectively). As expected, both  receptor-
mediated uptake and passive diffusion were involved.
Clinical validation of NRQ
To examine  the clinical applicability of NRQ,  lipid ac-
cumulation in monocytes isolated from both FH patients 
and  obese  subjects  who  received  an  oral  fat  load  were 









(I) using 10–14 independent images.
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subjects  showed a mild  increase  in TG  levels upon oral 
ingestion of fat (summarized in Table 1). Analyses of mono-
cyte lipid content using the NRQ showed that FH patients 
had  a  significant  increase  in  neutral  LD-positive  mono-
cytes (63 ± 6.3% for healthy subjects vs. 81 ± 6.6% for FH 
patients; Fig. 4A) and neutral LDs per monocyte (1.395 ± 
0.167-fold; Fig. 4B)  increased  in FH patients compared 
with healthy controls (1.000 ± 0.045-fold; Fig. 3B). Mono-
cytes from obese subjects, isolated 4 h postprandially, 
showed a strong increase in neutral LD accumulation per 
LD-positive monocyte (1.806 ± 0.094-fold) compared with 
fasting state monocytes (Fig. 4D), although no differences 
were  found  in  neutral  LD-positive  monocytes  between 
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groups (Fig. 4C), most likely caused by increased baseline 
TG levels in obese subjects. This clinical pilot indicates that 
NRQ is able to detect in vivo differences in neutral LD con-
tent in circulating monocytes.
DISCUSSION
Here, we showed that the lipid dye, NR, is suitable for as-





for detecting alterations in LDL-induced neutral lipid accu-
mulation over  time (Fig.  3A–C) and  in a  concentration-
dependent manner  (supplemental  Fig.  S1B;  Fig.  3D–F). 
The validation of NR-based LD measurement revealed that 
it is a reliable tool to detect alterations in LD accumulation 
in circulating monocytes. NR has several advantages over 
other lipid probes or dyes: a) The lipophilic dye, NR, is in-
expensive as compared with antibody-based lipid probes. b) 
Cellular NR  staining  is  quick  and  easy  to  apply, whereas 
antibody-based procedures are time consuming due to the 
multiple staining steps. c) The fluorescence maxima fluctuate 
based on the hydrophobicity of NR allowing discrimination 
between  neutral  lipids  and  phospholipids.  This  enables 
specific detection of intracellular neutral lipids stored in 
LDs, whereas a lipid dye, such as BODIPY, may bind non-
specifically (16). Interestingly, NR stains phospholipids, 
which  allows  visualization of  the  cell membrane  (22). d) 




quently used lipid dye that is imaged using a bright-field 
microscope, which often cannot image in the Z-dimension. 
Without this dimension, it is more difficult to count and 
quantify all the lipids within one cell, because most LDs are 
not located in one focal plane, resulting in potential diffi-
culties in the quantification of LD content. In addition, the 
ORO-staining  procedure  causes  LDs  to  fuse  with  each 
other causing unreliable LD assessment (17). e) Further 
validation  of  NR  applicability  revealed  its  usefulness  in 
staining  of  other  cell  types,  such  as  THP-1  cells, murine 
bone marrow-derived macrophages (data not shown), and 
human fibroblasts (data not shown).
Automated image analysis using NRQ
Because of its sensitivity, the NRQ quantification tool al-
lows  the  analysis  of  time-dependent  increase  of  LD  con-
tent. We  showed  that NRQ  is  suitable  to  replace manual 
counting of intracellular LDs in circulating monocytes, as 






take caution concerning the amount of cells per FOV. Too 
many cells per FOV could result in cell clusters that are too 
dense, leading to difficulties in semi-automated quantifica-
tion of single cells (data not shown). Therefore, we recom-
mend  maximal  seeding  of  1  ×  105  monocytes/cm2 for 




manually  determined  LD  count.  This  phenomenon  was 
most likely caused by the accuracy of detecting LDs by the 




strictly  determine  whether  a  sample  is  positive  or  not, 
where manual detection of LDs remains arbitrary. In addi-




Implications for clinical research
Research into lipid accumulation focused predominantly 
on plaque macrophages; however, recent findings highlight 
Fig. 4.  Clinical  validation  of NRQ. A,  B:  LD-positive monocytes 
(A) and LDs per LD-positive monocyte (B)  in FH patients. C, D: 
LD-positive monocytes (C) and LDs per LD-positive monocyte (D) 
before and 4 h after oral fat administration. P < 0.05 considered 
significant. Data  are  shown  as mean  ±  SD  for  n  =  3  patients  per 
group.
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the importance of the interaction between lipoproteins and 
mononuclear cells already in the circulation (28, 29, 37). 
Foamy  monocytes  have  been  shown  to  contribute  to  
nascent atherosclerosis (38). Intracellular lipid accumulation 
induces 2-integrin (CD11c/CD18) surface expression (39), 
which plays an important role as a compatible structure for 
vascular  cellular  adhesion  molecules  on  endothelial  cells, 




monocytes become saturated upon lipid loading, as can be 
seen in Fig. 3B, C, E, and F. LD accumulation of monocytes 
tended to show rapid uptake (after 5 min) and saturation af-
ter 10 min of LDL incubation. This might be attributed to the 
lack of efflux mechanisms in an ex vivo experimental setup. 
This absence of plasma cholesterol efflux mechanisms, such 
as high density cholesterol, may induce an accelerated accu-
mulation response. This is due to the lack of opportunities to 
efflux cholesterol (41). To substantiate this, it was found that 















ducible method for intracellular quantification of LD con-
tent, there are some limitations to discuss. One possible 




the  violet  spectrum  (405 nm),  in  order  to  perform dual 
localization studies using NR (43, 44). The diameter of LDs 
in nonadipocytes generally range from 0.1 m, but can be 









for quick and reproducible NR-based lipid detection in iso-
lated patient-derived circulating monocytes. NRQ measures 
the total number of lipids per FOV and the number of LD-
positive cells. With these parameters, one can quantify LD 
content on a per cell basis and the percentage of lipid posi-
tive cells. We also revealed that, besides circulating mono-
cytes, NRQ is also applicable for THP-1 cells, suggesting its 
potential for other cell types. Additionally, the NR staining 
procedure is sensitive enough to detect any changes in LD 
dynamics and NRQ is a useful tool for analysis of shifts in 
neutral  LD  content  in  patient-derived  circulating mono-
cytes. In addition, NRQ could be helpful to standardize 
the field of LD imaging and analysis. Furthermore, it would 
be  interesting  to  see whether  increased LD accumula-
tion  and,  hence,  increased  pro-inflammatory  phenotype 
could be used as a possible biomarker  for cardiovascular 
risk assessment.
The  authors  would  like  to  thank  Miranda  Versloot  for  her 
technical  assistance  with  the  THP-1  experiments.  Servier 
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